PTCT Competitors
PTC Therapeutics, Inc.
$59.35
-$0.57(-0.95%)
45
Overall
60
Value
18
Tech
57
Quality
Market Cap
$5.00B
Volume
934.18K
52W Range
$61.23 - $90.87
Target Price
$101.07
PTCT competitors: FATE, SRPT, VRTX, RNA, XNCR. PTC Therapeutics, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
PTCT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| FATE Fate Therapeutics, Inc. | $1.92 | $239.64M | $-1.03 | - | 40 |
| SRPT Sarepta Therapeutics, Inc. | $16.64 | $1.74B | $3.27 | - | 50 |
| VRTX Vertex Pharmaceuticals Incorporated | $498.71 | $122.98B | $16.65 | - | 51 |
| RNA Atrium Therapeutics, Inc. | $7.75 | $132.57M | $-5.08 | - | 20 |
| XNCR Xencor, Inc. | $23.44 | $1.75B | $-3.05 | - | 54 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTCT | $59.35 | -1.0% | 934.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |